Nevro Announces Acquisition of Vyrsa™ Technologies

Refinances with $200M Structured Debt Maturing in 2029 REDWOOD CITY, Calif., Nov. 30, 2023 /PRNewswire/ — Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic pain, today announced that it has…

Click here to view original post

Advertisement — Advertise with Biotech Networks